Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma

Summary

The researchers will investigate if modified T-cells from a patients own system can be utilized to find and destroy metastatic melanoma tumor and thus improve patient outcomes.

Timeline

Start

2016-10-06

Primary completion

2019-10-10

Completion

2021-09-13

Drugs

Indications